Cleared Special

Kawasumi Multiple Sample Adapter with Pre-Attached Holder (MBCH) (K223810) - FDA 510(k) Clearance

Class II General Hospital device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K223810 · Sb-Kawasumi Laboratories, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
66d
Days
Class 2
Risk

K223810 is an FDA 510(k) clearance for the Kawasumi Multiple Sample Adapter with Pre-Attached Holder (MBCH). Classified as Tubes, Vials, Systems, Serum Separators, Blood Collection (product code JKA), Class II - Special Controls.

Submitted by Sb-Kawasumi Laboratories, Inc. (Kawasaki-Shi, JP). The FDA issued a Cleared decision on February 24, 2023 after a review of 66 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 862.1675 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Sb-Kawasumi Laboratories, Inc. devices

Submission Details

510(k) Number K223810 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2022
Decision Date February 24, 2023
Days to Decision 66 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 129d · This submission: 66d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1675
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 100
Devices cleared under the same product code (JKA) and FDA review panel - the closest regulatory comparables to K223810.
BD Vacutainer® Push Button Blood Collection Set, BD Vacutainer® Push Button Blood Collection Set with Pre-Attached Holder
K220212 · Becton, Dickinson and Company · Mar 2023
Blood Collection Needle (with/without Needle Holder)
K223323 · Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. · Mar 2023
BD Vacutainer® Luer-Lok™ Access Device, BD Vacutainer® Blood Transfer Device
K222478 · Becton, Dickinson and Company · Mar 2023
Safety Push Button Blood Collection Set
K222834 · Jiangsu Caina Medical Co.,Ltd · Jan 2023
Steripath Micro Blood Collection System
K222299 · Magnolia Medical Technologies · Nov 2022
Eclipse Blood Collection Set
K213690 · Eclipse Medcorp, LLC · Oct 2022